Olig2 Antibody (OLIG2/7074R) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14218IR
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry-Paraffin
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Monoclonal Rabbit IgG Kappa Clone # OLIG2/7074R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant fragment (around aa200-300) of human Olig2 protein (exact sequence is proprietary) (Uniprot: Q13516)
Reactivity Notes
0
Localization
Nucleus, Cytoplasm
Marker
Marker of Glial Brain Tumors
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG Kappa
Applications for Olig2 Antibody (OLIG2/7074R) [DyLight 755]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Olig2
Long Name
Oligodendrocyte Lineage Transcription Factor 2
Alternate Names
BHLHB1, PRKCBP2, RACK17
Gene Symbol
OLIG2
Additional Olig2 Products
Product Documents for Olig2 Antibody (OLIG2/7074R) [DyLight 755]
Product Specific Notices for Olig2 Antibody (OLIG2/7074R) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...